Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
|Articles|September 15, 2006
Acidophilus Abates Adverse Antibiotic Effects
For patients who require long-term antibiotic therapy suggest they eat yogurt or take Lactobacillus acidophilus to reduce the risk of yeast infections and diarrhea.
Advertisement
For patients who require long-term antibiotic therapy (eg, for acne or rosacea), suggest that they regularly eat yogurt or take Lactobacillus acidophilus to reduce the risk of yeast infections and diarrhea. L acidophilus is available at health food stores and in many pharmacies. An added benefit of recommending acidophilus: it demonstrates an openness to more "natural" approaches, and this often improves relationships with patients.
-Benjamin Barankin, MD
Toronto
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
2
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
5